Back

Altered cellular VEGF dynamics in Chronic Obstructive Pulmonary Disease

Romano, M. d. P.; Ecke, P.; Tufvesson, E.; Singh Sohal, S.; Bjermer, L.; Schmidt, M.; Westergren-Thorsson, G.; Larsson-Callerfelt, A.-K.

2026-05-07 pathology
10.64898/2026.05.04.722512 bioRxiv
Show abstract

Pulmonary vascular remodelling is common in patients with chronic obstructive pulmonary disease (COPD). Vascular endothelial growth factors (VEGFs) are key mediators in angiogenesis and vascular remodelling and exist in different isoforms. VEGF-A is the most potent angiogenic member binding to VEGF receptor 2 (VEGFR2). There are, however, few studies on other isoforms, as VEGF-C, and its receptor VEGFR3 in COPD and subsequent impact of cAMP therapies on VEGF isoforms. Our aim was to evaluate the VEGF isoform synthesis in primary distal lung fibroblasts from control subjects (non-smokers (n=6) and ex-smokers (n=4), and COPD subjects with GOLD stage II (n=4) or GOLD stage IV (n=6), and the expression of VEGFR2 and VEGFR3 in human lung tissue. Primary lung fibroblasts were exposed to the cAMP generating therapies formoterol, iloprost, or roflumilast, the adenylyl cyclase activator forskolin or to transforming growth factor (TGF)-b1. VEGF isoforms were evaluated with ELISA. VEGF-C release was not significantly altered by TGF-{beta}1, in contrast to the increased levels of VEGF-A, in all fibroblasts. VEGF-C was significantly decreased by iloprost, forskolin and formoterol, whereas VEGF-A was significantly increased by iloprost and forskolin, with differences in release pattern between and within fibroblasts from control and COPD subjects. Exposure to VEGF-C specifically towards VEGFR3 decreased proliferative rate in human lung fibroblasts and bronchial epithelial cells. VEGFR2 and VEGFR3 were both present in parenchymal lung tissue and VEGFR2 in pulmonary blood vessels. in both healthy and COPD, whereas there was elevated expression of VEGFR3 in bronchial epithelium. In conclusion, TGF-{beta}1 and cAMP generating compounds have significant effects on VEGF-C and VEGF-A synthesis, which appear dysregulated in lung fibroblasts from ex-smokers and patients with COPD. Increased VEGFR3 expression in the bronchial epithelium in lung tissue, and studies into their functional impact, warrants further investigations.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 8%
19.6%
2
Respiratory Research
19 papers in training set
Top 0.1%
7.5%
3
International Journal of Molecular Sciences
453 papers in training set
Top 0.4%
7.1%
4
American Journal of Physiology-Lung Cellular and Molecular Physiology
39 papers in training set
Top 0.1%
5.1%
5
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.2%
5.1%
6
Frontiers in Pharmacology
100 papers in training set
Top 0.4%
5.1%
7
Critical Care
14 papers in training set
Top 0.1%
5.1%
50% of probability mass above
8
European Respiratory Journal
54 papers in training set
Top 0.4%
4.2%
9
Scientific Reports
3102 papers in training set
Top 29%
4.2%
10
FEBS Letters
42 papers in training set
Top 0.1%
2.0%
11
F1000Research
79 papers in training set
Top 1%
2.0%
12
Journal of Clinical Pathology
12 papers in training set
Top 0.1%
1.9%
13
Physiological Reports
35 papers in training set
Top 0.4%
1.7%
14
The FASEB Journal
175 papers in training set
Top 1%
1.4%
15
EBioMedicine
39 papers in training set
Top 0.6%
1.2%
16
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 1%
1.2%
17
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.7%
1.0%
18
Heliyon
146 papers in training set
Top 4%
0.9%
19
Virology
56 papers in training set
Top 0.5%
0.9%
20
Cells
232 papers in training set
Top 5%
0.8%
21
Medicine
30 papers in training set
Top 2%
0.8%
22
Molecular Biology Reports
19 papers in training set
Top 0.5%
0.8%
23
British Journal of Haematology
15 papers in training set
Top 0.4%
0.8%
24
Journal of Internal Medicine
12 papers in training set
Top 0.6%
0.8%
25
Tuberculosis
11 papers in training set
Top 0.2%
0.8%
26
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 1.0%
0.8%
27
Frontiers in Immunology
586 papers in training set
Top 9%
0.5%
28
Cancers
200 papers in training set
Top 5%
0.5%